Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

StemCyte Inc.

http://www.stemcyte.com

Latest From StemCyte Inc.

Watch this Space: Medtech in the Middle East

With all the frenzy of investing, partnering, and joint-venturing in emerging markets like China and India, where can medtech investors still get in on the ground floor? The Middle East. While capital for venture firms and their portfolio companies is growing scarcer in the US and Europe, government and private entities operating within the countries of the MENA (Middle East North Africa) region have billions--and in some cases trillions--to invest to further government goals of diversifying local economies beyond oil and real-estate while also improving their health care systems for their growing populations. Now, the former head of direct investment at the Kuwait Investment Authority is establishing a new $150 million investment fund that will focus on life sciences and telecommunications/IT in the region.

Middle East and Africa Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Biotechnology
    • Gene Therapy, Cell Therapy
UsernamePublicRestriction

Register